Heidelberg Pharma AG

Director's Dealing • Nov 27, 2017

News Details

Directors’ Dealings | 27 November 2017 09:25

DGAP-DD: Heidelberg Pharma AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

27.11.2017 / 09:25

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:	Dr.
First name:	Jan
Last name(s):	Schmidt-Brand

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Heidelberg Pharma AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A11QVV0

b) Nature of the transaction

Acquisition of shares by exercise of subscription rights

c) Price(s) and volume(s)

Price(s)	Volume(s)
2.60 EUR	68387.8 EUR

d) Aggregated information

Price	Aggregated volume
2.6000 EUR	68387.8000 EUR

e) Date of the transaction

2017-11-22; UTC+1

f) Place of the transaction

Outside a trading venue

---

27.11.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Heidelberg Pharma AG
	Schriesheimer Str. 101
	68526 Ladenburg
	Germany
Internet:	www.heidelberg-pharma.com

End of News	DGAP News Service